IONS

Ionis Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.52 1.14% 46.22 09:28:00
Open Price Low Price High Price Close Price Prev Close
45.70
more quote information »

Recent News

Date Time Source Heading
7/28/202207:05PRNUSIonis announces positive topline results from Phase 2b..
7/28/202206:12EDGARCurrent Report Filing (8-k)
7/27/202207:05PRNUSIonis to hold second quarter 2022 financial results webcast
7/26/202208:32DJNBiogen Gets FDA Priority Review of Tofersen in Rare Form of..
7/26/202207:30PRNUSIonis announces that FDA accepts New Drug Application and..
7/21/202223:45TRMNAnalysts Offer Insights on Healthcare Companies: BioMarin..
7/20/202207:05PRNUSIonis announces enrollment completion of Phase 3 Lp(a)..
7/19/202219:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202219:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202219:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202219:22EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202219:21EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202219:21EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202219:20EDGARStatement of Changes in Beneficial Ownership (4)
7/19/202219:20EDGARStatement of Changes in Beneficial Ownership (4)
7/14/202205:24TRMNIonis Pharmaceuticals (IONS) Gets a Hold Rating from SVB..
7/13/202207:05PRNUSIonis to participate in virtual fireside chat at H.C...
7/11/202210:14EDGARCurrent Report Filing (8-k)
7/11/202207:05PRNUSIonis partner licenses rare kidney disease treatment and..
7/06/202217:27EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202217:26EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202217:26EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202217:25EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202217:24EDGARStatement of Changes in Beneficial Ownership (4)
7/05/202209:25TRMNBMO Capital Maintains a Buy Rating on Ionis Pharmaceuticals..
6/25/202209:05PRNUSIonis announces presentation of positive Phase 2b data for..
6/21/202215:15TRMNNeedham Reiterates Their Buy Rating on Ionis Pharmaceuticals..
6/21/202204:44TRMNIonis Could be a Long-Term Winner; Here’s Why
6/21/202202:00PRNUSIonis announces eplontersen met co-primary and secondary..
6/14/202218:04EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202207:05PRNUSIonis treatment for Angelman syndrome receives orphan drug..
6/03/202205:20PRNUSIonis partner Biogen announces that results from Phase 3..
5/12/202207:05PRNUSIonis to present at RBC Capital Markets Global Healthcare..
5/08/202211:09TRMNSVB Securities Keeps a Hold Rating on Ionis Pharmaceuticals..
5/05/202221:46TRMNAnalysts’ Opinions Are Mixed on These Healthcare Stocks:..
5/04/202216:15TRMNIonis Pharmaceuticals (IONS) Gets a Buy Rating from Needham
5/04/202211:16EDGARCurrent Report Filing (8-k)
5/04/202207:00PRNUSIonis reports first quarter financial results and recent..
5/02/202207:05PRNUSIonis to host 2022 virtual Annual Meeting of Stockholders
4/20/202212:23EDGARProxy Statement (definitive) (def 14a)
4/20/202207:05PRNUSIonis to hold first quarter 2022 financial results webcast
4/14/202218:03EDGARStatement of Changes in Beneficial Ownership (4)
4/12/202206:35TRMNAnalysts Offer Insights on Healthcare Companies: Ionis..
4/11/202211:14EDGARAmended Statement of Ownership (sc 13g/a)
4/05/202218:28EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202206:34SEEKAstraZeneca, Ionis antisense drug helps reduce cholesterol..
4/04/202200:15PRNUSIonis announces positive data for ETESIAN Phase 2b study of..
4/01/202222:11TRMNIonis Pharmaceuticals (IONS) Initiated with a Hold at..
3/28/202208:31DJNBiogen, Ionis End Development of ALS Candidate After Study..
3/28/202207:30GLOBEBiogen and Ionis Announce Topline Phase 1 Study Results of..


Your Recent History
NASDAQ
IONS
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now